Kathy Pritchard‐Jones

32.9k total citations · 2 hit papers
311 papers, 12.3k citations indexed

About

Kathy Pritchard‐Jones is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kathy Pritchard‐Jones has authored 311 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Molecular Biology, 116 papers in Pulmonary and Respiratory Medicine and 101 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kathy Pritchard‐Jones's work include Renal and related cancers (175 papers), Renal cell carcinoma treatment (78 papers) and Childhood Cancer Survivors' Quality of Life (67 papers). Kathy Pritchard‐Jones is often cited by papers focused on Renal and related cancers (175 papers), Renal cell carcinoma treatment (78 papers) and Childhood Cancer Survivors' Quality of Life (67 papers). Kathy Pritchard‐Jones collaborates with scholars based in United Kingdom, France and United States. Kathy Pritchard‐Jones's co-authors include Janet Shipley, Linda King‐Underwood, Norbert Graf, Nicholas D. Hastie, Gordan Vujanić, Jonathan Bard, Wendy A. Bickmore, John Anderson, Filippo Spreafico and Jane Renshaw and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Kathy Pritchard‐Jones

301 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The candidate Wilms' tumour gene is involved in genitourinary development

1990 718 citations Kathy Pritchard‐Jones et al. profile →
Science and health for all children with cancer

2019 228 citations Kathy Pritchard‐Jones et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathy Pritchard‐Jones United Kingdom	63	8.1k	4.7k	3.2k	1.9k	1.6k	311	12.3k
Carlos Rodríguez‐Galindo United States	63	2.6k 0.3×	3.7k 0.8×	2.0k 0.6×	4.1k 2.2×	1.4k 0.9×	356	13.7k
Giulio J. D’Angio United States	60	6.0k 0.7×	4.7k 1.0×	2.5k 0.8×	1.7k 0.9×	1.0k 0.6×	279	13.1k
Gregory H. Reaman United States	68	4.2k 0.5×	2.1k 0.5×	4.9k 1.6×	3.6k 1.9×	6.3k 4.0×	306	15.8k
Lisa Diller United States	53	2.9k 0.4×	1.3k 0.3×	3.4k 1.1×	3.3k 1.8×	2.4k 1.5×	220	10.8k
Holcombe E. Grier United States	57	2.0k 0.3×	5.7k 1.2×	3.0k 0.9×	2.4k 1.3×	2.5k 1.6×	145	11.7k
Charles Stiller United Kingdom	63	2.6k 0.3×	2.9k 0.6×	5.5k 1.7×	3.4k 1.8×	5.2k 3.3×	223	13.9k
Richard Sposto United States	67	3.3k 0.4×	2.0k 0.4×	1.8k 0.6×	3.4k 1.8×	2.5k 1.6×	282	13.4k
Frederick P. Li United States	50	5.8k 0.7×	2.7k 0.6×	1.5k 0.5×	5.7k 3.0×	1.3k 0.8×	131	13.8k
Neyssa Marina United States	51	1.8k 0.2×	3.6k 0.8×	3.5k 1.1×	2.2k 1.2×	2.1k 1.4×	160	9.8k
Mark Krailo United States	76	4.5k 0.6×	6.8k 1.5×	1.9k 0.6×	5.7k 3.1×	2.0k 1.3×	392	18.7k

Countries citing papers authored by Kathy Pritchard‐Jones

Since Specialization

Citations

This map shows the geographic impact of Kathy Pritchard‐Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Pritchard‐Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Pritchard‐Jones more than expected).

Fields of papers citing papers by Kathy Pritchard‐Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Pritchard‐Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Pritchard‐Jones. The network helps show where Kathy Pritchard‐Jones may publish in the future.

Co-authorship network of co-authors of Kathy Pritchard‐Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Pritchard‐Jones. A scholar is included among the top collaborators of Kathy Pritchard‐Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Pritchard‐Jones. Kathy Pritchard‐Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al‐Saadi, Reem, Rhoikos Furtwängler, Norbert Graf, et al.. (2025). The Clinical Impact of Somatic Copy Number Variations in Patients With Stage IV Wilms Tumor Enrolled in the SIOP 2001 Trial and Study. Pediatric Blood & Cancer. 72(4). e31580–e31580.

Botta, Laura, Adela Cañete, Emmanuel Désandes, et al.. (2025). International benchmarking of stage at diagnosis for six childhood solid tumours (the BENCHISTA project): a population-based, retrospective cohort study. The Lancet Child & Adolescent Health. 9(2). 89–99. 5 indexed citations

Vujanić, Gordan, Norbert Graf, Ellen D’Hooghe, et al.. (2024). Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience. Pediatric Blood & Cancer. 71(3). e30852–e30852. 1 indexed citations

Camargo, Beatriz de, Harm van Tinteren, C. Bergeron, et al.. (2022). International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study. JCO Global Oncology. 8(8). e2100425–e2100425. 16 indexed citations

Jackson, Thomas J., Hervé J. Brisse, Kathy Pritchard‐Jones, et al.. (2022). How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group. Pediatric Blood & Cancer. 69(9). e29702–e29702. 16 indexed citations

Mifsud, William, Rhoikos Furtwängler, Christian Vokuhl, et al.. (2022). Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studies. European Journal of Cancer. 166. 1–7. 3 indexed citations

Laszlo, Helga, Edward Seward, Ruth M Ayling, et al.. (2021). Faecal immunochemical test for patients with ‘high-risk’ bowel symptoms: a large prospective cohort study and updated literature review. British Journal of Cancer. 126(5). 736–743. 16 indexed citations

Goodfellow, Henry, et al.. (2021). The multidisciplinary, theory-based co-design of a new digital health intervention supporting the care of oesophageal cancer patients. Digital Health. 7. 569682122–569682122. 13 indexed citations

Irtan, Sabine, Harm van Tinteren, Norbert Graf, et al.. (2019). Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial. European Journal of Cancer. 116. 13–20. 21 indexed citations

10.

Dome, Jeffrey S., Norbert Graf, James I. Geller, et al.. (2015). Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. Journal of Clinical Oncology. 33(27). 2999–3007. 235 indexed citations

11.

Missiaglia, Edoardo, Dan Williamson, Julia Chisholm, et al.. (2012). PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification. Journal of Clinical Oncology. 30(14). 1670–1677. 230 indexed citations

12.

Oldenburger, Foppe, et al.. (2011). IS THE RADIOTHERAPY BOOST TO MACROSCOPIC RESIDUAL TUMOR INDICATED?. UCL Discovery (University College London). 1 indexed citations

13.

Williams, Richard D., Reem Al‐Saadi, Tasnim Chagtai, et al.. (2010). Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor. Clinical Cancer Research. 16(7). 2036–2045. 55 indexed citations

14.

Williamson, Daniel, Edoardo Missiaglia, Aurélien de Reyniès, et al.. (2010). Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma. Journal of Clinical Oncology. 28(13). 2151–2158. 326 indexed citations

15.

Pritchard‐Jones, Kathy, et al.. (2010). Recent Developments in the Molecular Pathology of Paediatric Renal Tumours. 4(1). 4 indexed citations

16.

Grundy, Paul, et al.. (2010). SIGNIFICANCE OF LYMPH NODE INVOLVEMENT IN NEPHROBLASTOMA. UCL Discovery (University College London). 4 indexed citations

17.

Drake, Kylie M., E. Cristy Ruteshouser, Rachael Natrajan, et al.. (2009). Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562. Clinical Cancer Research. 15(19). 5985–5992. 51 indexed citations

18.

Prasad, Rashmi B., Fay J. Hosking, Jayaram Vijayakrishnan, et al.. (2009). Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood. 115(9). 1765–1767. 91 indexed citations

19.

Vuononvirta, Raisa, Neil J. Sebire, Boo Messahel, et al.. (2009). Expression of Hepatocyte Growth Factor and Its Receptor Met in Wilms' Tumors and Nephrogenic Rests Reflects Their Roles in Kidney Development. Clinical Cancer Research. 15(8). 2723–2730. 5 indexed citations

20.

Williamson, Daniel, Joanna Selfe, Tony Gordon, et al.. (2007). Role for Amplification and Expression of Glypican-5 in Rhabdomyosarcoma. Cancer Research. 67(1). 57–65. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact